Idenix Pharmaceuticals, Inc. · Cambridge, MA United States · (NASDAQ (GM): IDIX)
Company Description
More Companies in: Cambridge, Massachusetts
More Companies in These Related Industries: Pharmaceutical Preparation Mfg
View Idenix Pharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Idenix Pharmaceuticals is not suffering from any identity crisis -- it is clear in its focus on identifying treatments for life-threatening viruses. The biopharmaceutical firm is developing orally administered drugs to combat chronic hepatitis C (HCV) and HIV. Its lead HIV product candidate is in early clinical stages; its HCV candidates are in preclinical testing. Most are intended to be taken in combination with other therapeutic agents to improve efficacy and convenience. Under a development and commercialization agreement, Novartis has the option to license any of the product candidates developed by Idenix. Novartis owns 56% of Idenix. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Idenix Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports for this company now.
Download presentation-ready reports for this company now.
From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.
Key Idenix Pharmaceuticals, Inc. Financials
| Company Type | Public - NASDAQ (GM): IDIX Headquarters |
| Fiscal Year-End | December |
| 2009 Employees | 144 |
Idenix Pharmaceuticals, Inc. Executives
28 executives listed for Idenix Pharmaceuticals, Inc.'s Cambridge, MA location.
| Title | Name & Bio | Contact |
| Chairman, President, and CEO | Jean-Pierre Sommadossi | |
| CFO and Treasurer | Ronald Renaud | |
| EVP and Chief Medical Officer | Douglas Mayers |
Competition
Top Idenix Pharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!